CryoXtract, a subsidiary of Allied Minds, specializes in advanced sample processing technologies that focus on frozen aliquotting solutions. Their primary product, the CXT 353, is designed to enhance the integrity of biological samples by eliminating the need for thawing during aliquotting. This approach is particularly beneficial for research applications in molecular pathology, microbiome analysis, and bioanalysis, where maintaining the stability of nucleic acids, proteins, and metabolites is crucial. By preserving samples in a continuously frozen state, CryoXtract ensures that valuable material remains uncontaminated and reliable for subsequent analyses, thereby improving the quality and repeatability of research outcomes.

The company also emphasizes the customization of workflows and solutions tailored to specific research needs. CryoXtract's capabilities allow for the integration of existing methodologies into bespoke systems that enhance biobanking processes and quality assurance. Their focus on safer and standardized processing methods addresses common challenges in sample handling, particularly in the context of microbiota research, where the integrity of samples can significantly impact the results. Overall, CryoXtract's technologies aim to provide researchers with innovative tools that facilitate accurate and reproducible scientific investigations.

United States

CryoXtract is a biobanking company that specializes in automated solutions for preserving biospecimen integrity and improving data quality.

CryoXtract (Allied Minds)

Company Details